What's new

Human medicines European public assessment report (EPAR): Vimkunya, Chikungunya vaccine (recombinant, adsorbed), Date of authorisation: 28/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Vimkunya, Chikungunya vaccine (recombinant, adsorbed), Date of authorisation: 28/02/2025, Status: Authorised

Mar 24, 2025 - 11:32
 0
Human medicines European public assessment report (EPAR): Vimkunya, Chikungunya vaccine (recombinant, adsorbed), Date of authorisation: 28/02/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Vimkunya, Chikungunya vaccine (recombinant, adsorbed), Date of authorisation: 28/02/2025, Status: Authorised
Read More

Tags:

Previous Article

Taj Hotel to open in Alibaug, Maharashtra, expanding IHCL’s luxury portfolio

Next Article

Nucleation driving force-controlled fibril network formation enables polythiophe...

Related Posts

Human medicines European public assessment report (EPAR): GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.), budesonide,formoterol fumarate dihydrate, Date of authorisation: 03/04/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Interested Parties to the HMPC

Interested Parties to the HMPC

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Date of authorisation: 22/05/2012, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0